Project Description


The Alzheimer Center Limburg / Cognitive Neuropsychiatry and Clinical Neurosciences group (CN&CN) of Maastricht University has a long track record and high international reputation regarding clinical research on cognitive disorders, especially dementia. The group (>30 fte) has a large national and international network in the field of normal and pathological brain ageing, including the European collaboration on psychosocial interventions in dementia (INTERDEM) and the European Alzheimer’s Disease Association (EADC), and has been involved in several 6th and 7th EU Framework Programmes.

The Maastricht team consists of Frans Verhey, Marjolein de Vugt, Claire Wolfs, Ron Handels and Hilde Verbeek.

FVerheyProf. Dr. Frans R.J. Verhey is a professor of Old Age Psychiatry/ Neuropsychiatry at Maastricht University. He is the present chair of the research division Cognitive Neuropsychiatry and Clinical Neurosciences at the research school MHeNS. and the director of the Alzheimer Center Limburg. He is internationally recognized as an active clinical researcher in the field of Alzheimer’s disease and related disorder.


vugtDr Marjolein de Vugt, PhD, has more than ten years experience and  expertise in neurodegenerative disorders including diagnosis and psychosocial  treatment of mild cognitive impairment, early stage dementia and young onset  dementia. She is currently working as a health care psychologist at the Memory clinic of the Academic Hospital Maastricht, where she is supervisor of Psychology students, junior neuropsychologists and health care psychologist trainees. Dr de Vugt is chair  of the Alzheimer Center Limburg (ACL). She is associate professor and leader of the research program ‘innovative interventions for dementia caregivers’.

wolfDr. Claire Wolfs works as a post-doc researcher at Maastricht University and is also  following a traineeship for health care psychology at Maastricht University. She is involved with studies relating to neurodegenerative disorders  since 2002 including the effectiveness and cost-effectiveness of diagnostic techniques, but more recently also with psychosocial treatment of mild cognitive impairment and (early stage) dementia. Wolfs conducted a study (which dr. de Vugt initiated and coordinated) into factors that predict (non)utilization of treatment  and care options in dementia (‘Choices in care’), funded by the Dutch research institute  for care and medical science.


ronRon Handels (MSc) is a PhD student at Maastricht University. He finished the Health Sciences Research Master in 2010. Ron Handels’ research focus is on health technology assessment. Currently he works on the LeARN project “Novel diagnostic approaches for the diagnosis of Alzheimer’s disease: Technology Assessment and Clinical effectiveness”. Handels will be collaborating intensively with professor Wimo from Karolinska Institutet regarding the Economic evaluation (workpackage 4).



veerbekDr. Hilde Verbeek is an Assistant Professor at the Department of Health Services Research, Maastricht University and coordinator of the Academic Collaborative Centre Care on Older People. At the Academic Collaborative Center innovative solutions in care for the elderly are being developed, assessed and implemented. Her research focuses on long-term care environments for older people, in particular those with dementia.






Frans R.J.Verhey / Dr. Marjolein E. de Vugt
Maastricht University, Department of Psychiatry and Neuropsychology
P.O. Box 5800, 6202 AZ Maastricht
The Netherlands
T 0031 43 3874175 + F 0031 43 3875444



This project is supported locally by funding from ZonMW – The Netherlands Organisation for   Health Research and Development, under the aegis of JPND (